Board of Directors and Key Personnel
- Mr. Sanjay Vyankatesh Kulkarni (Non-Executive Chairman)
- Mr. Bharat Brijmohan Sharma (Managing Director & CEO)
- Mrs. Srijna Bharat Sharma (Whole time Director)
- Mr. Munna Baijnath Chaurasia (Independent Director)
- Mr. Aman Mukesh Chaudhari (Independent Director)
- Mr. Anagh Sharma (Chief Financial Officer)
- Mrs. Priti Bhaiya (Company Secretary & Compliance Officer)
Banker: Union Bank of India
Statutory Auditor: Banka & Banka Chartered Accountants, Shah Trade Centre 3rd floor, above State Bank of India, Rani Sati Marg, Malad East, Mumbai-400 097
Share Registrar & Transfer Agent: KFin Technologies Limited, Selenium, Tower - B, Plot No. 31 & 32, Financial District, Nanakramguda, Serilingampally, Hyderabad, Rangareddi, Telangana - 500032
Annual General Meeting Details
The 37th Annual General Meeting will be held on Saturday, September 26, 2026 at 4:30 p.m. at the registered office of the Company.
Cut-off date for determining member eligibility: Friday, September 18, 2026
Remote e-voting period: Wednesday, September 23, 2026 (9:00 A.M.) to Friday, September 25, 2026 (5:00 P.M.) through Central Depository Services Limited (CDSL)
Book closure period: Sunday, September 20, 2026 to Saturday, September 26, 2026 (both days inclusive)
Business to be Transacted
Ordinary Business:
1. Adoption of Audited Financial Statements for financial year ended March 31, 2026
2. Appointment of Mr. Sanjay Kulkarni (DIN: 00065190) who retires by rotation
Special Business:
3. Re-appointment of Mr. Bharat Brijmohan Sharma as Managing Director & Chief Executive Officer for three years from April 01, 2026 to March 31, 2029
MD Reappointment Details
Mr. Bharat Brijmohan Sharma (DIN: 00077026) proposed for re-appointment as MD & CEO with following remuneration terms:
- Salary including allowances and incentives: Not exceeding ₹21,60,000 per annum
- Additional perquisites: conveyance allowance, transport allowance, medical reimbursement, leave travel allowance, company car for official purposes, telephone at residence, PF contributions, superannuation fund, gratuity, leave encashment
- No sitting fees for Board or Committee meetings
- Minimum remuneration provision in case of inadequate profits, subject to Central Government approval
Financial Performance Comparison
| Particulars | Year ended March 31, 2026 | Year ended March 31, 2025 |
| Total Income | ₹310.70 lakh | ₹307.33 lakh |
| Less: Expenditure | ₹297.77 lakh | ₹297.86 lakh |
| Profit/(loss) before Tax | ₹12.93 lakh | ₹9.47 lakh |
| Tax Expense | ₹2.78 lakh | ₹1.57 lakh |
| Profit/(Loss) after tax | ₹10.15 lakh | ₹7.90 lakh |
Director Information
Mr. Bharat Brijmohan Sharma: B. Pharma qualification, 38 years experience in pharma industry, associated with company since inception, promoter of the company holding 19,96,085 shares, past remuneration ₹21,60,000 paid during FY 2025-26.
Mr. Sanjay V. Kulkarni: B.Com qualification, 72 years old, 40+ years experience in pharmaceutical marketing, appointed to Board on April 01, 2012, holds no shares in the company.
Additional Information
- No foreign investments or collaborations
- Scrutinizer appointed: Mr. Gaurav Thakur (Membership No. 25622, FRN: 007437) of M/s. Gaurav Thakkur & Co.
- Annual Report includes Standalone Financial Statements as per Section 129(3) of Companies Act, 2013
- Documents available for inspection at registered office during business hours
- Route map attached for AGM venue directions